611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Health Tip: Help Prevent Bone FracturesLater-Life Fractures Up Risk of Early DeathAir Pollution at National Parks Keeps Visitors AwayIn the ICU, Patients' Relatives Often Mum About Care ConcernsHealth Tip: Prevent Bed Bugs at HomeHealth Tip: Treating Heat-Related IllnessU.S. Deaths From Liver Disease Rising RapidlySupplement May Ease the Pain of Sickle Cell DiseaseAHA: Vaping Tied to Blood Clots -- in MiceHealth Tip: Performing the Heimlich ManeuverThe Latest on Chronic Fatigue SyndromeAHA: Protect Your Heart and Health During 'Dog Days' of SummerHealth Tip: Care For an Incision After SurgeryAs Ticks Reach Record Numbers, Take PrecautionsObesity Adds to Burden of Traumatic Brain InjuryHidden Blood in Feces May Signal Deadly ConditionsFirst Drug to Treat Smallpox ApprovedVitamin D No Panacea for Brain DiseasesEczema Dramatically Impacts Quality of LifeTo Fend Off Migraines, Try Keeping a Headache DiaryAHA: Soccer Is Called the Beautiful Game, But Injuries Can Make It a Dangerous One100 Now Sickened by Salmonella-Tainted Honey Smacks CerealA 3-Pronged Plan to Cut Type 2 Diabetes RiskCan You Eat Your Way to Better Asthma Control?Are Concussions Tougher on Athletes With ADHD?Lyme-Bearing Ticks More Widespread in U.S. Than ThoughtHealth Tip: Shingles 101High Blood Pressure Threatens Aging Brain, Study SaysNeurological Fallout From Ebola Infection Worse Than ThoughtReport Warns of Dog Illness That Can Spread to OwnersHealth Tip: Caring for Your Epi-PenMore Evidence That Supplements Won't Help Your HeartHealth Tip: Asbestos Tips For HomeownersGerms Grow on Medical Implants, But Can They Make You Sick?FDA Drops Zika Testing for Blood Donors850 Million People Worldwide Have Kidney DiseaseAs Temperatures Soar, Study Warns of Fatal Heat Stroke at WorkFatigue Fuels Knee Injuries in Young AthletesWarming Climate, More AC -- and More Unhealthy Smog AheadHealth Tip: Understanding West Nile VirusCould Flea Fighters Stem Spread of Diseases Like Zika?Even Once-a-Week Pot Smokers Have More Cough, PhlegmZika Dangers During Pregnancy May Be Worse Than ThoughtHealth Tip: Use a Blood Thinner SafelyBeat the Heat on Your Summer VacationSitting Tied to Raised Risk of Death From 14 DiseasesCataract Surgery Tied to Fewer Car Crashes for Seniors'Walk & Think' Test Could Be Key to Concussion CareJuly Is Peak Time for Illness From Poop in Pools: CDCCould Estrogen Play a Role in Men's Migraines?
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

AHA: Acetylcysteine, Sodium Bicarbonate Don't Cut Renal Risk


HealthDay News
Updated: Nov 13th 2017

new article illustration

MONDAY, Nov. 13, 2017 (HealthDay News) -- For patients at high risk for renal complications who are scheduled for angiography, there is no benefit with intravenous sodium bicarbonate over sodium chloride or with oral acetylcysteine over placebo, according to a study published online Nov. 12 in the New England Journal of Medicine to coincide with the American Heart Association's Scientific Sessions, being held Nov. 11 to 15 in Anaheim, California.

Steven D. Weisbord, M.D., from the Veterans Affairs Pittsburgh Healthcare System and the University of Pittsburgh School of Medicine, and colleagues randomized 5,177 patients at high risk for renal complications who were scheduled for angiography to receive intravenous sodium bicarbonate or sodium chloride and five days of oral acetylcysteine or placebo. The trial was stopped after a prespecified interim analysis, and 4,993 patients were included in the modified intention-to-treat analysis.

The researchers found that there was no interaction between sodium bicarbonate and acetylcysteine with respect to the primary end point (P = 0.33), which was a composite of death, need for dialysis, or a persistent increase of at least 50 percent in the serum creatinine level from baseline to 90 days. The primary end point occurred in 4.4 and 4.7 percent of patients in the sodium bicarbonate and sodium chloride groups (odds ratio, 0.93; 95 percent confidence interval, 0.72 to 1.22; P = 0.62) and in 4.6 and 4.5 percent of patients in the acetylcysteine and placebo groups (odds ratio, 1.02; 95 percent confidence interval, 0.78 to 1.33; P = 0.88).

"There was no benefit of intravenous sodium bicarbonate over intravenous sodium chloride or of oral acetylcysteine over placebo for the prevention of death, need for dialysis, or persistent decline in kidney function at 90 days or for the prevention of contrast-associated acute kidney injury," the authors write.

Several authors disclosed financial ties to pharmaceutical and medical device companies.

Abstract/Full Text
More Information